AWmeta Empowers Adaptively Weighted Transcriptomic Meta-Analysis

Area of Science:

• Genomics
• Bioinformatics
• Computational Biology

Background:

• Transcriptomic meta-analysis integrates multiple studies to identify differentially expressed genes (DEGs).
• Existing methods using p-values or effect sizes have limitations in detecting subtle yet crucial gene signatures.
• There is a need for more powerful and robust meta-analytical approaches for transcriptomic data.

Purpose of the Study:

• To introduce AWmeta, a novel adaptively weighted framework for transcriptomic meta-analysis.
• To unify p-value and effect-size meta-analytical paradigms.
• To improve the identification of high-fidelity DEGs and enhance biological veracity in complex diseases.

Main Methods:

• Developed AWmeta, an adaptively weighted meta-analysis framework.
• Benchmarked AWmeta on 35 Parkinson's and Crohn's disease transcriptomic datasets.
• Compared AWmeta against the random-effects model (REM) and constituent studies.

Main Results:

• AWmeta identified higher-fidelity DEGs with fewer false positives compared to REM.
• The framework demonstrated robust gene differential expression quantification.
• AWmeta successfully prioritized biologically relevant, tissue-contextual genes for Parkinson's and Crohn's disease.

Conclusions:

• AWmeta offers a more accurate and reliable method for transcriptomic meta-analysis.
• The framework enhances the identification of disease-specific gene signatures.
• AWmeta serves as a valuable tool for precision transcriptomic integration and mechanistic insights.